Patient Care
Education
Research
Community
Referring Physicians
Find a Physician
Departments & Centers
About URMC
Libraries
Alumni
Giving
URMC
»
Clinical Trials
»
Participate
A-
A
A+
Email this page
URMC Health Research
Participate in a Study
Open Studies
FAQ
About Clinical Research
Research at URMC
Healthy Volunteers
Links
Contact Us
ResearchMatch
Multiple Myeloma Clinical Trials
1.
(CMMY04001) S0115 - A Phase II Trial Evaluating Modified High Dose Melphalan (100mg/m2) and Autologous Peripheral Blood Stem Cell Supported Transplantation (SCT) for High Risk Patients with Multiple Myeloma and/or Light Chain Amyloidosis (AL Amyloidosis) (A BMT Study)
2.
(CMMY08094) (E1A06)An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) Versus Melphalan, Prednisone and Lenalidomide (Revlimid(tm)) (MPR) in Newly Diagnosed Multiple Myeloma Patients who are not Candidates for High-Dose Therapy.
3.
(UMMY05011) A Pilot Phase-I Trial of Rabbit Anti-Thymocyte Clobulin (rATG, Thymoglobulin) in Combintaiton with Rapamycin in Relapsed Multiple Myeloma (MM).
4.
(CMMY08093) (S0777)- A Randomized Phase III Trial of CC-5013 (Lenalidomide, NSC-703813) and Low Dose Dexamethasone (LLD) Versus Bortezomib (PS-341, NSC-681239), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma without an Intent for Immeadiate Autologous Stem Cell Transplant.
Email this page
